| Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck MO Rodríguez, TC Rivero, R del Castillo Bahi, CR Muchuli, MA Bilbao, ... Cancer biology & therapy 9 (5), 343-349, 2010 | 234 | 2010 |
| Bivalent binding by intermediate affinity of nimotuzumab: a contribution to explain antibody clinical profile G Garrido, IA Tikhomirov, A Rabasa, E Yang, E Gracia, N Iznaga, ... Cancer biology & therapy 11 (4), 373-382, 2011 | 175 | 2011 |
| Pharmacodynamic trial of nimotuzumab in unresectable squamous cell carcinoma of the head and neck: a SENDO Foundation study F Rojo, E Gracias, N Villena, T Cruz, JM Corominas, I Corradino, ... Clinical Cancer Research 16 (8), 2474-2482, 2010 | 101 | 2010 |
| Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study) C Messina, AJM Ferreri, S Govi, M Bruno‐Ventre, EA Gracia Medina, ... British journal of haematology 164 (6), 834-840, 2014 | 66 | 2014 |
| Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patients E Gracia, P Froesch, L Mazzucchelli, V Martin, D Rodríguez-Abreu, ... Leukemia & lymphoma 48 (1), 104-108, 2007 | 58 | 2007 |
| Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study M Osorio, E Gracia, E Rodríguez, G Saurez, M del Carmen Arango, ... Cancer biology & therapy 7 (4), 488-495, 2008 | 51 | 2008 |
| Patterns of survival of follicular lymphomas at a single institution through three decades A Conconi, M Motta, F Bertoni, C Piona, A Stathis, L Wannesson, E Gracia, ... Leukemia & lymphoma 51 (6), 1028-1034, 2010 | 34 | 2010 |
| The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the bone S Govi, D Christie, C Messina, MB Ventre, EAG Medina, D Porter, ... Annals of oncology 25 (1), 176-181, 2014 | 31 | 2014 |
| Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma M Osorio, E Gracia, E Reigosa, J Hernandez, A de la Torre, G Saurez, ... Cancer management and research, 341-345, 2012 | 29 | 2012 |
| The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study … S Govi, D Christie, S Mappa, E Marturano, M Bruno-Ventre, C Messina, ... Leukemia & lymphoma 55 (8), 1796-1799, 2014 | 24 | 2014 |
| Los «Millennials», una Población Marcada por la tecnología J García, E Medina El Tiempo. Recuperado de https://www. eltiempo. com/archivo/documento/CMS …, 2016 | 11 | 2016 |
| Pharmacodynamic study of nimotuzumab, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb), in patients with unresectable squamous cell carcinoma of the … F Rojo, E Gracias, N Villena, T Cruz, I Corradino, M Cedeño, C Campas, ... Journal of Clinical Oncology 26 (15_suppl), 6070-6070, 2008 | 11 | 2008 |
| Low prevalence of Chlamydia psittaci infection in ocular adnexal lymphoma (OAL) from Cuban patients E Gracia Ann Oncol. 16 (5), v126, 2005 | 11 | 2005 |
| International Extranodal Lymphoma Study Group (IELSG): Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the … C Messina, AJ Ferreri, S Govi, M Bruno-Ventre, EA Gracia Medina, ... Br J Haematol 164 (6), 834-840, 2014 | 9 | 2014 |
| Survival of NSCLC patients treated with cimavax-EGF as switch maintenance in the real-world scenario YIF Vega, DLP González, SCA Sarmiento, LEA Tul, IBI Valdés, ... Journal of Cancer 14 (5), 874, 2023 | 8 | 2023 |
| Patterns of outcome and prognostic factors in primary bone lymphoma (osteolymphoma): a survey of 499 cases by the International Extranodal Lymphoma Study Group DRH Christie, E Gracia, M Gospodarowicz, G Martinelli, K Deans, ... Haematologica, 2007 | 8 | 2007 |
| Inequity in cancer care: A global perspective A AC08917459 IAEA, 2011 | 7 | 2011 |
| Binding properties of the anti-EGFR monoclonal antibody, nimotuzumab, limit interaction with the EGFR in renal and epidermal cells G Garrido, A Rabasa, E Gracia, I Tikhomirov, R Perez CANCER RESEARCH 69, 2009 | 7 | 2009 |
| HOLA COVID-19 study: evaluating the impact of caring for patients with COVID-19 on cancer care delivery in Latin America C Bernabe-Ramirez, AI Velazquez, C Olazagasti, C Decat Bergerot, ... JCO global oncology 8, e2100251, 2022 | 5 | 2022 |
| Bombeo De Agua Para Riego En Cerro Calán Utilizando Energía Solar Fotovoltaica EA Medina SANTIAGO-CHILE, 2009 | 4 | 2009 |
Tania Crombet Ramos, MD, PhDClinical Research Director, Center of Molecular Immunology, Havana, Cuba在 cim.sld.cu 的电子邮件经过验证
